Rhabdomyosarcoma is a highly malignant tumor with striated muscle differentiation, which is histologically classified as alveolar, embryonal, pleomorphic, and spindle cell/sclerosing histological subtype. Rhabdomyosarcoma with rearrangement, which usually occurs in the bone, is a newly identified rare spindle and epithelioid rhabdomyosarcoma with characteristic clinicopathological features and molecular alterations. We report a 39-year-old female patient who underwent local excision of the mandibular lesion. Microscopically, the intraosseous tumor was composed of spindle-shaped, epithelioid, and rhabdomyoblastic cells with atypical nuclei and atypical mitotic figures. In addition, rearrangement was revealed by the fluorescence in situ hybridization. The tumor was thus correctly diagnosed as rhabdomyosarcoma with rearrangement. The patient was scheduled to undergo radiotherapy, and triple-agent chemotherapy after surgery, and no tumor recurrence or metastasis was detected during the 3-month postoperative follow up. Since this tumor is relatively rare and newly recognized, it can be easily misdiagnosed or missed and might be a conundrum of pathological diagnosis. Familiarity with its clinicopathological features and molecular alterations is essential for its correct diagnosis. Therefore, we summarized the clinicopathological, immunohistochemical, and molecular alterations of 43 cases of this rare rhabdomyosarcoma variant in the English-language literature. In addition, the differential diagnosis of this lesion is crucial either.

Download full-text PDF

Source
http://dx.doi.org/10.1177/10668969241239676DOI Listing

Publication Analysis

Top Keywords

rhabdomyosarcoma rearrangement
12
molecular alterations
12
spindle epithelioid
8
epithelioid rhabdomyosarcoma
8
clinicopathological features
8
features molecular
8
rhabdomyosarcoma
6
tumor
5
rare
4
rare case
4

Similar Publications

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, presenting with heterogeneous clinical and molecular subtypes. While gene fusions are predominantly associated with alveolar RMS, spindle cell RMS, especially congenital and intraosseous variants, are also linked to specific gene fusions. Furthermore, recently, FGFR1 kinase-driven RMSs were published.

View Article and Find Full Text PDF

EWSR1/FUS::TFCP2-rearranged rhabdomyosarcoma (RMS) is a rare tumor with an aggressive clinical course, a predilection for craniofacial bones, spindled and/or epithelioid histomorphology, and positive immunohistochemistry (IHC) for epithelial and myogenic markers, along with variable ALK expression. Herein, we present four additional cases of primary cutaneous TFCP2-rearranged RMS. Notably, one tumor (case 1) displayed a varied pathological spectrum, initially presenting as a low-grade spindle cell neoplasm, but progressed into a high-grade spindle/epithelioid tumor.

View Article and Find Full Text PDF
Article Synopsis
  • Rhabdomyosarcomas (RMS), particularly the alveolar subgroup, are prevalent in children and adolescents, with significant genetic features including common translocations of specific genes.
  • The study analyzed 32 tumor samples using various methods, revealing 81% had rearrangements at the FOXO1 locus, and identified translocation partners in most samples.
  • The findings highlighted genetic diversity in alveolar RMS, with four distinct cytogenetic patterns observed, and noted that approximately 20% of cases showed no signs of genetic rearrangement.
View Article and Find Full Text PDF
Article Synopsis
  • CIC-rearranged sarcomas (CRS) are aggressive tumors often driven by a specific fusion gene (CIC::DUX4), which can be difficult to detect through molecular testing due to variability in the fusion breakpoints.* -
  • The study evaluated the effectiveness of DUX4 immunohistochemistry (IHC) in identifying CRS by analyzing 48 confirmed CRS cases alongside 105 non-CRS cases across various types of tumors.* -
  • DUX4 IHC showed a sensitivity of 98% and specificity of 100% for diagnosing CRS, making it a reliable marker to assist in detecting these tumors, despite one false negative case involving a different fusion.*
View Article and Find Full Text PDF

Hi-C sequencing is a DNA-based next-generation sequencing method that preserves the 3D genome conformation and has shown promise in detecting genomic rearrangements in translational research studies. To evaluate Hi-C as a potential clinical diagnostic platform, analytical concordance with routine laboratory testing was assessed using primary pediatric leukemia and sarcoma specimens. Archived viable and non-viable frozen leukemic cells and formalin-fixed paraffin-embedded (FFPE) tumor specimens were analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!